Rapcabtagene autoleucel (YTB323) for patients with first line high-risk large B-cell lymphoma: Phase II interim results


Por: Westin, J, Chavez, J, Schuster, SJ, Vucinic, V, Young, PA, Johnson, PC, Bramanti, S, Rambaldi, A, Meijide, JB, Kato, K, Sancho, JM, Kwon, M, Solano, C, Fleming, S, Dahiya, S, Garcia-Sancho, AM, Ramos, PM, Pearson, D, Diallo, S, Zia, A, Segura, E, Masood, A and Barba, P

Publicada: 1 dic 2025 Ahead of Print: 1 dic 2025
Resumen:


Filiaciones:
Westin, J:
 MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX USA

Chavez, J:
 H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

Schuster, SJ:
 Univ Penn, Abramson Canc Ctr, Lymphoma Program, Philadelphia, PA USA

Vucinic, V:
 Univ Hosp Leipzig, Dept Hematol Cellular Therapy Hemostaseol & Infect, Leipzig, Germany

Young, PA:
 Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, David Geffen Sch Med, Los Angeles, CA USA

Johnson, PC:
 Harvard Med Sch, Massachusetts Gen Hosp, Div Hematol & Oncol, Boston, MA USA

Bramanti, S:
 IRCCS Humanitas Res Hosp, Humanitas Canc Ctr, Milan, Rozzano Milano, Italy

Rambaldi, A:
 Univ Milan, Dept Oncol & Hematol, Bergamo, Italy

 ASST Papa Giovanni XXIII, Bergamo, Italy

Meijide, JB:
 Hosp Santa Creu & Sant Pau, Hematol Serv, Barcelona, Spain

Kato, K:
 Kyushu Univ Hosp, Dept Hematol Oncol & Cardiovasc Med, Fukuoka, Japan

:
 Hosp Germans Trias i Pujol, Clin Hematol Dept, ICO IJC, Badalona, Spain

Kwon, M:
 Complutense Univ Madrid UCM, Hosp Gen Univ Gregorio Maranon, Gregorio Maranon Hlth Res Inst IiSGM, Fac Med,Dept Hematol, Madrid, Spain

Solano, C:
 Hosp Clin Univ INCLIVA Valencia, Hematol Serv, Valencia, Spain

Fleming, S:
 Alfred Hosp, Dept Haematol, Melbourne, Australia

 Monash Univ, Australian Ctr Blood Dis, Melbourne, Australia

Dahiya, S:
 Stanford Univ, Sch Med, Div Blood & Marrow Transplantat & Cellular Therapy, Stanford, CA USA

Garcia-Sancho, AM:
 Univ Salamanca, Hosp Univ Salamanca, Dept Hematol, IBSAL,CIBERONC, Salamanca, Spain

Ramos, PM:
 Novartis Pharm AG, Basel, Switzerland

Pearson, D:
 Novartis BioMed Res, Basel, Switzerland

Diallo, S:
 Novartis Pharm AG, Basel, Switzerland

Zia, A:
 Novartis Pharm AG, Basel, Switzerland

Segura, E:
 Novartis Pharmaceut, Madrid, Spain

Masood, A:
 Novartis Pharmaceut, E Hanover, NJ USA

Barba, P:
 H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

 Hosp Univ Vall dHebron, Dept Hematol, Barcelona, Spain
ISSN: 00064971





Blood
Editorial
American Society of Hematology, 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 146 Número:
Páginas: 670-671
WOS Id: 001659056200021

MÉTRICAS